Manufacturer Solutions
Cell and Gene Therapy
Your therapy can make all the difference. Together, we’ll unlock its potential.
Accelerating healthier futures
As healthcare advances, so must the processes that connect patients to the therapies they need. Each patient's path to treatment is unique. And because a rapidly evolving cell and gene therapy industry requires an equally innovative partner, AmerisourceBergen is committed to delivering solutions that enable this connection.
Every innovator needs a connector. We exist to connect you.
For therapy developers
Distribution and Commercialization Services
From pre-clinical and commercial logistics to distribution and order to cash solutions, our experts can help you navigate the right options for your therapy. Our extensive reach has served patients for clinical trials and commercial distribution in the US, and in more than 50 countries worldwide.
For providers
Market Access and Reimbursement
We’ve helped commercially support 100% of the cell and gene therapies on the market today. Our experts offer market access, reimbursement and specific therapeutic area insights to help therapy developers understand the unique market landscape.
For patients
Impacting Patient Support
Hub services provide a holistic and comprehensive approach to ongoing patient support. We have the flexibility to design unique programs incorporating a full array of access, adherence and affordability solutions that meet patient needs.
With the launch of the CGT Integration Hub, which is platform-agnostic and powered by AmerisourceBergen’s innovative customer relationship management (CRM) system, we can complete platform integrations with various supply chain partners, including therapy developers and CGT software providers.
For example, AmerisourceBergen recently completed a platform integration with TrakCel’s cell orchestration platform OCELLOS.
For example, AmerisourceBergen recently completed a platform integration with TrakCel’s cell orchestration platform OCELLOS.
Working together with therapy developers to identify and overcome barriers
Redefining moments that matter
We approach every touchpoint along the cell and gene therapy commercialization and treatment timeline with the patient in mind. When we all collaborate to deliver potentially life-saving solutions, we can start redefining the moments that matter for patients, clinicians and our key stakeholders.
Complete data solutions provide visibility to the patient journey
- Innovative patient access, affordability and adherence solutions unique to cell and gene therapies
- Expert guidance on market access, reimbursement and policy
- Complete logistics support, from pre-clinical through clinical trials to commercialization and post-launch solutions to ensure product quality standards are maintained
- Established relationships with thousands of healthcare providers optimizes the order to cash process and ease of prodcut access
"AmerisourceBergen has a proven history of bringing complex and transformative therapies to market. But like our cell and gene therapy partners, we're always looking ahead. We want to innovate because there will be new challenges as the field evolves. We are committed to co-creating innovative solutions to meet those challenges."
Lung-I Cheng
Vice President, Cell and Gene Therapy
AmerisourceBergen
AmerisourceBergen
Our partnerships
Collaboration is essential to the creation of clinical and commercial scale logistics platforms. In order to support therapy developers, we have integrated systems and technology with a number of key partner organizations.
- Vineti
- Cytiva
- TrakCel
- BioLife Solutions
- Advanced Therapies Treatment Centres
Biopharma services
Each investment we make is focused on connecting healthcare stakeholders to accelerate healthier futures. Our unrivaled expertise powers us in our vision to help you fully realize your product’s power—through the patients it reaches and the strategic outcomes it delivers. Learn more about our end to end suite of commercialization solutions for biopharma companies.
Let's work together to envision new paths to healthier futures around the world.
Cell and Gene Therapy Insights
